These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24989312)

  • 1. [Role of miR-155 in pathogenesis of diffuse large B cell lymphoma and its possible mechanism].
    Shi JS; Zhang J; Li J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):869-72. PubMed ID: 24989312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma.
    Jia YJ; Liu ZB; Wang WG; Sun CB; Wei P; Yang YL; You MJ; Yu BH; Li XQ; Zhou XY
    Leukemia; 2018 Mar; 32(3):703-711. PubMed ID: 29135973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma.
    Gu L; Song G; Chen L; Nie Z; He B; Pan Y; Xu Y; Li R; Gao T; Cho WC; Wang S
    Acta Haematol; 2013; 130(2):87-94. PubMed ID: 23548551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma.
    Huang X; Shen Y; Liu M; Bi C; Jiang C; Iqbal J; McKeithan TW; Chan WC; Ding SJ; Fu K
    Am J Pathol; 2012 Jul; 181(1):26-33. PubMed ID: 22609116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Hodgkin's lymphoma: the old and the new.
    Cabanillas F
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S87-90. PubMed ID: 22035756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
    Yao XX; Wang JF; Wang YH; Gao N
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Wu PY; Zhang XD; Zhu J; Guo XY; Wang JF
    Hum Pathol; 2014 Aug; 45(8):1664-73. PubMed ID: 24931464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
    Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
    Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells.
    Jablonska E; Gorniak P; Szydlowski M; Sewastianik T; Bialopiotrowicz E; Polak A; Warzocha K; Juszczynski P
    Exp Hematol; 2017 Feb; 46():56-61.e1. PubMed ID: 27720936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiomirs expression profiling in diffuse large B-Cell lymphoma.
    Borges NM; do Vale Elias M; Fook-Alves VL; Andrade TA; de Conti ML; Macedo MP; Begnami MD; Campos AH; Etto LY; Bortoluzzo AB; Alves AC; Young KH; Colleoni GW
    Oncotarget; 2016 Jan; 7(4):4806-16. PubMed ID: 26683099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.
    Kluiver J; Poppema S; de Jong D; Blokzijl T; Harms G; Jacobs S; Kroesen BJ; van den Berg A
    J Pathol; 2005 Oct; 207(2):243-9. PubMed ID: 16041695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and clinical significance of miR-21 in diffuse large B cell lymphoma].
    Li CH; Fu R; Wang YH; Song WJ; Ruan EB; Qu W; Wang HQ; Wang GJ; Song J; Wang XM; Wu YH; Xing LM; Liu H; Li LJ; Guan J; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):339-43. PubMed ID: 24763002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of miR-224 in diffuse large B cell lymphoma and its clinical significance].
    Song G; Gu L; He B; Pan Y; Wang S
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):619-22. PubMed ID: 25052605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis.
    Rai D; Kim SW; McKeller MR; Dahia PL; Aguiar RC
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3111-6. PubMed ID: 20133617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198.
    Wang R; Shen J; Wang Q; Zhang M
    Biomed Pharmacother; 2018 Dec; 108():43-49. PubMed ID: 30216798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
    Xu ZZ; Xia ZG; Wang AH; Wang WF; Liu ZY; Chen LY; Li JM
    Ann Hematol; 2013 Oct; 92(10):1351-8. PubMed ID: 23636313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.
    Marques SC; Ranjbar B; Laursen MB; Falgreen S; Bilgrau AE; Bødker JS; Jørgensen LK; Primo MN; Schmitz A; Ettrup MS; Johnsen HE; Bøgsted M; Mikkelsen JG; Dybkær K
    Exp Hematol; 2016 Apr; 44(4):238-46.e2. PubMed ID: 26854484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.
    Singh RR; Kim JE; Davuluri Y; Drakos E; Cho-Vega JH; Amin HM; Vega F
    Leukemia; 2010 May; 24(5):1025-36. PubMed ID: 20200556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment].
    Cao QW; Li HY; Yao XX; Wang JF
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1010-4. PubMed ID: 23363792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DEPTOR is a microRNA-155 target regulating migration and cytokine production in diffuse large B-cell lymphoma cells.
    Jabłońska E; Białopiotrowicz E; Szydłowski M; Prochorec-Sobieszek M; Juszczyński P; Szumera-Ciećkiewicz A
    Exp Hematol; 2020 Aug; 88():56-67.e2. PubMed ID: 32702393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.